THE ACTIVATION REGION OF THE TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FUNCTIONS IN YEAST

被引:9
|
作者
SUBRAMANIAN, T [1 ]
DSAEIPPER, C [1 ]
ELANGOVAN, B [1 ]
CHINNADURAI, G [1 ]
机构
[1] ST LOUIS UNIV,MED CTR,INST MOLEC VIROL,ST LOUIS,MO 63110
关键词
D O I
10.1093/nar/22.8.1496
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The N-terminal 48 amino acids of the Tat protein of human immunodeficiency virus type (HIV)-1 constitute its activation region. This region can autonomously activate transcription when targeted to the HIV-1 long terminal repeat or certain heterologous promoters either through DNA binding sites located upstream of the transcription initiation site or via downstream RNA binding sites in mammalian cells. To determine whether the Tat activation region can function in yeast, we have assayed the effect of a chimeric gene (GAL - Tat48) expressing the DNA binding domain of the yeast transcription factor Gal4 (residues 1-147) and the activation region of Tat on GAL1 promoter-directed expression of the lacZ reporter gene in Saccharomyces cerevisiae. Our results indicate that the Gal-Tat48 fusion protein can induce significant activation of the GAL1 promoter. Analysis of a number of Tat mutants located within the activation region indicate that the amino acid residues of Tat essential for trans-activation in mammalian cells are also required for transactivation in yeast. Our results suggest that Tat-mediated transcriptional activation may involve a mechanism conserved among yeast and mammalian cells.
引用
收藏
页码:1496 / 1499
页数:4
相关论文
共 50 条
  • [41] RECIPROCAL MODULATIONS BETWEEN P53 AND TAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LI, CJ
    WANG, CL
    FRIEDMAN, DJ
    PARDEE, AB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5461 - 5464
  • [42] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT ACTIVITY BY COEXPRESSION OF HETEROLOGOUS TRANS ACTIVATORS
    CARROLL, R
    PETERLIN, BM
    DERSE, D
    JOURNAL OF VIROLOGY, 1992, 66 (04) : 2000 - 2007
  • [43] MUTATIONAL DEFINITION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV ACTIVATION DOMAIN
    MALIM, MH
    MCCARN, DF
    TILEY, LS
    CULLEN, BR
    JOURNAL OF VIROLOGY, 1991, 65 (08) : 4248 - 4254
  • [44] RANDOM MUTAGENESIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATOR OF TRANSCRIPTION (HIV-1 TAT)
    SIDEROVSKI, DP
    MATSUYAMA, T
    FRIGERIO, E
    CHUI, S
    MIN, X
    ERFLE, H
    SUMNERSMITH, M
    BARNETT, RW
    MAK, TW
    NUCLEIC ACIDS RESEARCH, 1992, 20 (20) : 5311 - 5320
  • [45] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [46] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [47] ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENHANCER IS NOT DEPENDENT ON NFAT-1
    MARKOVITZ, DM
    HANNIBAL, MC
    SMITH, MJ
    COSSMAN, R
    NABEL, GJ
    JOURNAL OF VIROLOGY, 1992, 66 (06) : 3961 - 3965
  • [48] CHEMICAL SYNTHESIS OF BIOLOGICALLY-ACTIVE TAT TRANS-ACTIVATING PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHUN, R
    GLABE, CG
    FAN, H
    JOURNAL OF VIROLOGY, 1990, 64 (06) : 3074 - 3077
  • [49] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480
  • [50] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148